PCSK9-inhibitor drugs: A game-changer for patients with extremely high cholesterol levels

Share it
[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][fusion_text]Research conducted at UT Southeastrn has resulted in new drugs tScreen Shot 2016-03-30 at 1.01.34 PMhat are having major positive implications for patients who are at risk from high cholesterol levels. The new drugs were approved by the FDA last summer and are already helping individuals.

 

Published by UT Southwestern Medical Center by Newswise on 2/25/16/. 

Continue Reading.[/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

See more news